Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03948763
Title A Study of mRNA-5671/V941 as Monotherapy and in Combination With Pembrolizumab (V941-001)
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Merck Sharp & Dohme Corp.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NZL | AUS

Facility Status City State Zip Country Details
Banner MD Anderson Cancer Center ( Site 1008) Gilbert Arizona 85234 United States Details
City of Hope ( Site 1002) Duarte California 91010 United States Details
University of California at San Francisco ( Site 1006) San Francisco California 30322 United States Details
Smilow Cancer Hospital at Yale New Haven ( Site 1005) New Haven Connecticut 06510 United States Details
Dana-Farber Cancer Institute (Boston) ( Site 1007) Boston Massachusetts 02215 United States Details
Comprehensive Cancer Centers of Nevada ( Site 1012) Las Vegas Nevada 89169 United States Details
Tennessee Oncology Nashville Drug Development Unit ( Site 7000) Nashville Tennessee 37203 United States Details
START San Antonio ( Site 1004) San Antonio Texas 78229 United States Details
Baylor Scott & White Medical Center - Temple ( Site 1009) Temple Texas 76508 United States Details
Northwest Medical Specialties, PLLC ( Site 1001) Tacoma Washington 98405 United States Details
Kinghorn Cancer Centre ( Site 6000) Darlinghurst New South Wales 2010 Australia Details
Southern Oncology Clinical Research Unit SOCRU ( Site 6002) Bedford Park South Australia 5042 Australia Details
Monash Health-Monash Medical Centre ( Site 6001) Clayton Victoria 3168 Australia Details
Prince of Wales Hospital ( Site 2002) Hong Kong Hong Kong Details
Queen Mary Hospital ( Site 2001) Hong Kong Hong Kong Details
Asan Medical Center ( Site 0802) Songpagu Seoul 05505 Korea, Republic of Details
Seoul National University Hospital ( Site 0801) Seoul 03080 Korea, Republic of Details
Severance Hospital ( Site 0800) Seoul 03722 Korea, Republic of Details
New Zealand Clinical Research (Christchurch) ( Site 6501) Christchurch Canterbury 8011 New Zealand Details
Auckland City Hospital ( Site 6500) Auckland 1023 New Zealand Details
National University Hospital ( Site 3006) Singapore Central Singapore 119074 Singapore Details
National Cancer Centre Singapore ( Site 3005) Singapore Central Singapore 169610 Singapore Details
Tan Tock Seng Hospital ( Site 3007) Singapore Central Singapore 398442 Singapore Details
National Cheng Kung University Hospital ( Site 4002) Tainan 704 Taiwan Details
National Taiwan University Hospital ( Site 4000) Taipei 10002 Taiwan Details
Taipei Veterans General Hospital ( Site 4001) Taipei 11217 Taiwan Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field